Global nocturia market to reach $8.5b by 2034

Its growth is attributed to an ageing population and a rise in chronic diseases.

The global market for nocturia, a condition characterised by frequent nighttime urination, is projected to reach $8.5b by 2034 at a compound annual growth rate of 8%, said Transparency Market Research.

The sector’s expansion is attributed to an ageing population, a rise in chronic diseases like diabetes and hypertension,

Furthermore, developments in diagnostic tools and treatment options, including anticholinergic drugs, desmopressin, and behavioural therapies, are driving demand.

Meanwhile, increasing awareness of urinary health and the availability of treatment options are further fueling the market’s growth.

“Healthcare providers are focusing on early diagnosis and personalised treatment plans,” the report said.